Nine-month operating profit stable at 8.15 billion euros / Nine-month net income attributable to shareholders up 3.9 percent to 5.20 billion euros / Quarterly operating profit down 7.5 percent to 2.45 billion euros / Quarterly net income attributable to shareholders decreases by 15.4 percent to 1.36 billion euros / Targeted shift in Life product mix improves profitability for new business / Strong Solvency II capitalization of 200 percent